ImmuCell Corp. (Nasdaq: ICCC), a Portland-based biotech company that makes health products for cattle, last week posted double-digit sales increases for both the fourth quarter and full year of 2021. The company also shrank its net loss for the year.
During the three-month period ended Dec. 31, 2021, sales grew by 45%, or $1.7 million, over the same period a year earlier, to $5.4 million. Sales for all of 2021 increased by 25%, or $3.9 million, over 2020 to $19.2 million. Read more